Found 27 matching trials
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients N/A A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...
Show More Location
Shanghai Dongfang Hospital
Learn More & Join Trial
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer NA The investigators propose to conduct a single-center, single-arm, Phase I c...
Show More Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
Learn More & Join Trial
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer PHASE2 This study is a Prospective, Single-arm, Phase 2 clinical trial. The purpos...
Show More Location
Fudan University Shanghai Cancer Cente
Learn More & Join Trial
A Phase Ib/II Clinical Study of LBL-024 Combination Therapy in Patients With Metastatic Colorectal Carcinoma PHASE1 This study is an open-label, multi-center Phase Ib/II clinical trial evalua...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer PHASE2 This study is a single-arm, open, phase II clinical trial aimed at evaluati...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma PHASE2 The goal of this prospective, interventional clinical trial is to evaluatio...
Show More Learn More & Join Trial
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage PHASE2 A single-arm, phase II study was designed to evaluate the efficacy and safe...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC) N/A The expanded access program allows people to gain access to an unlicensed t...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer PHASE3 Fruquintinib/Placebo 5 mg, QD, orally administered under fasting conditions...
Show More Location
307 Hospital of PLA
Learn More & Join Trial
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors PHASE1 This study aims to evaluate the efficacy of CVL218 in combination with Tori...
Show More Location
Multiple Locations
Learn More & Join Trial